Short and Long Term Fampridine Treatment in Persons With Multiple Sclerosis: Cognitive and Motor Performances
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2018
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms FAMPISEP
- 17 Jul 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
- 17 Jul 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2019.
- 01 Aug 2016 New trial record